Tyvaso 0.6 MG refill kit
Ended Awarded Last action
- Contract number
- 36C24526N0376
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $15,746
Award facts
- Contract value 100% obligated
- $15,746.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order valued at $15,746.12 to United Therapeutics Corp for Tyvaso 0.6 mg refill kits, with a completion date of March 3, 2026. This delivery order, issued under the General Services Administration's Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB), carries a firm fixed-price structure with no set-aside designation applied. The pharmaceutical product will be delivered to a facility in Bartlett, Tennessee, and represents a direct procurement from United Therapeutics under the company's existing blanket purchase agreement with the VA.
This delivery order is executed under United Therapeutics Corp's $207.1 million single-award Blanket Purchase Agreement with the Department of Veterans Affairs National Acquisition Center, which became effective April 24, 2025. Tyvaso (treprostinil) inhalation solution is a critical therapeutic agent used to treat pulmonary arterial hypertension, a rare and life-threatening condition affecting some veterans. As the sole contractor under this BPA, United Therapeutics supplies this specialized medication and three other pharmaceutical products—Unituxin, Remodulin, and Orenitram—to Veterans Integrated Service Networks nationwide at pre-negotiated prices, enabling the VA to maintain reliable, cost-predictable access to these essential treatments across its integrated healthcare network.
Quick answers
Who was awarded contract 36C24526N0376?
36C24526N0376 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 25, 2026.
How much is contract 36C24526N0376 worth?
The government has obligated $15,746 on 36C24526N0376.
Is contract 36C24526N0376 an order under another contract?
Yes. 36C24526N0376 is a delivery order under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0376 competed?
The extent of competition for 36C24526N0376 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award